세계의 지혈 제품 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2034년)
Hemostasis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1530976
리서치사:Transparency Market Research
발행일:2024년 06월
페이지 정보:영문 213 Pages
라이선스 & 가격 (부가세 별도)
한글목차
지혈 제품 시장 - 조사 범위
TMR의 조사 보고서 ``지혈 제품 세계 시장''은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 본 보고서는 2024년을 기준년, 2034년을 예측년으로 하여 2018년부터 2034년까지 세계 지혈제품 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 지혈제품 시장의 복합 연간 성장률(CAGR%)도 제공합니다.
이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 지혈 제품 시장을 추찰했습니다.
시장 현황
2023년 시장 규모
25억 달러
2034년 시장 규모
45억 달러
CAGR
5.7%
이 보고서는 세계 지혈 제품 시장 경쟁 구도를 조사했습니다. 세계 지혈 제품 시장에서 사업을 전개하는 주요 기업이 확인되고 각 기업은 다양한 속성으로 프로파일 링됩니다. 기업 개요, 재무상황, 최근 동향, SWOT 등이 본 보고서에서 소개되고 있는 세계의 지혈제품 시장에서의 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약: 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
국가/지역별 규제 시나리오
세계 지혈 시장의 주요 브랜드
주요 산업 이벤트(제품 출시, 주요 합병 및 인수 등)
COVID-19에 의한 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 제품별
소개 및 정의
주요 조사 결과· 발전
시장 매출 예측 : 제품별, 2020-2034년
국소
주입 가능
첨단
시장의 매력 분석 : 제품별
제7장 세계 시장 분석과 예측 : 용도별
소개 및 정의
주요 조사 결과· 발전
시장 매출 예측 : 용도별, 2020-2034년
외상
수술
기타
시장의 매력 분석 : 용도별
제8장 세계 시장 분석과 예측 : 최종 사용자별
소개 및 정의
주요 조사 결과· 발전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원
외래수술센터(ASC)
기타
시장의 매력 분석 : 최종 사용자별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 :지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 분석 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 구도
시장기업-경쟁 매트릭스(기업 Tier과 규모별)
시장 점유율 분석기업별(2023년)
기업 프로파일
Pfizer, Inc.
Baxter International
Medtronic plc
Abbott
B. Braun Melsungen AG
Johnson & Johnson(Ethicon)
CSL
Becton, Dickinson, and Company
Precision Biologics
Sysmex Corporation
JHS
영문 목차
영문목차
Hemostasis Products Market - Scope of Report
TMR's report on the global hemostasis products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hemostasis products market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemostasis products market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hemostasis products market.
Market Snapshot
Market Value in 2023
US$ 2.5 Bn
Market Value in 2034
US$ 4.5 Bn
CAGR
5.7%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemostasis products market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hemostasis products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemostasis products market.
The report delves into the competitive landscape of the global hemostasis products market. Key players operating in the global hemostasis products market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hemostasis products market profiled in this report.
Key Questions Answered in Global hemostasis products Market Report:
What is the sales/revenue generated by hemostasis products across all regions during the forecast period?
What are the opportunities in the global hemostasis products market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Hemostasis Products Market - Research Objectives and Research Approach
The comprehensive report on the global hemostasis products market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global hemostasis products market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hemostasis products market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemostasis Products Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemostasis Products Market Analysis and Forecast, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario by Country/Region
5.2. Leading Brands in the Global Hemostasis Market
5.3. Key Industry Events (Product Launch, Key Mergers and Acquisitions, etc.)
5.4. Covid-19 Impact on Industry
6. Global Hemostasis Products Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Topical Hemostasis Products
6.3.1.1. Gelatin
6.3.1.2. Polysaccharides
6.3.1.3. Oxidized Regenerated Cellulose
6.3.1.4. Collagen
6.3.2. Infusible Hemostasis Products
6.3.2.1. Platelet Concentrate from Donor Blood
6.3.2.2. Fresh Frozen Plasma (FFP)
6.3.2.3. Factor VIII
6.3.2.4. Prothrombin
6.3.3. Advanced Hemostasis Products
6.3.3.1. Flowable
6.3.3.2. Thrombin
6.3.3.3. Synthetic Sealants
6.3.3.4. Fibrin
6.4. Market Attractiveness Analysis, by Product
7. Global Hemostasis Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Trauma
7.3.2. Surgery
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Hemostasis Products Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Hemostasis Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Hemostasis Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2020-2034
10.2.1. Topical Hemostasis Products
10.2.1.1. Gelatin
10.2.1.2. Polysaccharides
10.2.1.3. Oxidized Regenerated Cellulose
10.2.1.4. Collagen
10.2.2. Infusible Hemostasis Products
10.2.2.1. Platelet Concentrate from Donor Blood
10.2.2.2. Fresh Frozen Plasma (FFP)
10.2.2.3. Factor VIII
10.2.2.4. Prothrombin
10.2.3. Advanced Hemostasis Products
10.2.3.1. Flowable
10.2.3.2. Thrombin
10.2.3.3. Synthetic Sealants
10.2.3.4. Fibrin
10.3. Market Value Forecast, by Application, 2020-2034
10.3.1. Surgery
10.3.2. Trauma
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Hemostasis Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2020-2034
11.2.1. Topical Hemostasis Products
11.2.1.1. Gelatin
11.2.1.2. Polysaccharides
11.2.1.3. Oxidized Regenerated Cellulose
11.2.1.4. Collagen
11.2.2. Infusible Hemostasis Products
11.2.2.1. Platelet Concentrate from Donor Blood
11.2.2.2. Fresh Frozen Plasma (FFP)
11.2.2.3. Factor VIII
11.2.2.4. Prothrombin
11.2.3. Advanced Hemostasis Products
11.2.3.1. Flowable
11.2.3.2. Thrombin
11.2.3.3. Synthetic Sealants
11.2.3.4. Fibrin
11.3. Market Value Forecast, by Application, 2020-2034
11.3.1. Surgery
11.3.2. Trauma
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Hemostasis Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2020-2034
12.2.1. Topical Hemostasis Products
12.2.1.1. Gelatin
12.2.1.2. Polysaccharides
12.2.1.3. Oxidized Regenerated Cellulose
12.2.1.4. Collagen
12.2.2. Infusible Hemostasis Products
12.2.2.1. Platelet Concentrate from Donor Blood
12.2.2.2. Fresh Frozen Plasma (FFP)
12.2.2.3. Factor VIII
12.2.2.4. Prothrombin
12.2.3. Advanced Hemostasis Products
12.2.3.1. Flowable
12.2.3.2. Thrombin
12.2.3.3. Synthetic Sealants
12.2.3.4. Fibrin
12.3. Market Value Forecast, by Application, 2020-2034
12.3.1. Surgery
12.3.2. Trauma
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Hemostasis Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2020-2034
13.2.1. Topical Hemostasis Products
13.2.1.1. Gelatin
13.2.1.2. Polysaccharides
13.2.1.3. Oxidized Regenerated Cellulose
13.2.1.4. Collagen
13.2.2. Infusible Hemostasis Products
13.2.2.1. Platelet Concentrate from Donor Blood
13.2.2.2. Fresh Frozen Plasma (FFP)
13.2.2.3. Factor VIII
13.2.2.4. Prothrombin
13.2.3. Advanced Hemostasis Products
13.2.3.1. Flowable
13.2.3.2. Thrombin
13.2.3.3. Synthetic Sealants
13.2.3.4. Fibrin
13.3. Market Value Forecast, by Application, 2020-2034
13.3.1. Surgery
13.3.2. Trauma
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Hemostasis Products Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2020-2034
14.2.1. Topical Hemostasis Products
14.2.1.1. Gelatin
14.2.1.2. Polysaccharides
14.2.1.3. Oxidized Regenerated Cellulose
14.2.1.4. Collagen
14.2.2. Infusible Hemostasis Products
14.2.2.1. Platelet Concentrate from Donor Blood
14.2.2.2. Fresh Frozen Plasma (FFP)
14.2.2.3. Factor VIII
14.2.2.4. Prothrombin
14.2.3. Advanced Hemostasis Products
14.2.3.1. Flowable
14.2.3.2. Thrombin
14.2.3.3. Synthetic Sealants
14.2.3.4. Fibrin
14.3. Market Value Forecast, by Application, 2020-2034
14.3.1. Surgery
14.3.2. Trauma
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2020-2034
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Pfizer, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Baxter International
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Medtronic plc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Abbott
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. B. Braun Melsungen AG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Johnson & Johnson (Ethicon)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. CSL
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Becton, Dickinson, and Company
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Precision Biologics
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Sysmex Corporation
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
